$GILD 8-K/A SEC Filings

Filed On	Filing
13 Dec 2024	8-K/A: Departure/Election of Directors or Officers; Compensation Foster City, Calif., Dec. 12, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will become a member of Gilead’s senior leader...
06 Jan 2021	8-K/A: Completion of Acquisition or Disposition of Assets
18 May 2017	8-K/A: Submission of Matters to a Vote of Security Holders
25 Jul 2016	8-K/A: Results of Operations and Financial Condition
22 Mar 2012	8-K/A: Completion of Acquisition or Disposition of Assets
17 Jul 2009	8-K/A: Entry into a Material Definitive Agreement
14 Aug 2008	8-K/A: Departure/Election of Directors or Officers; Compensation
10 May 2007	8-K/A: Departure/Election of Directors or Officers; Compensation
09 Feb 2007	8-K/A: Departure/Election of Directors or Officers; Compensation
01 Feb 2007	8-K/A: Completion of Acquisition or Disposition of Assets
22 Feb 2006	8-K/A: Entry into a Material Definitive Agreement
01 Feb 2006	8-K/A: Departure/Election of Directors or Officers; Compensation
08 May 2003	8-K/A: Completion of Acquisition or Disposition of Assets
13 Mar 2003	8-K/A: Completion of Acquisition or Disposition of Assets

Comments